Genetic polymorphisms in the MMP-2 and MMP-9 genes and breast cancer phenotype
- 1 December 2004
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 88 (3) , 197-204
- https://doi.org/10.1007/s10549-004-0595-6
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinomaBritish Journal of Cancer, 2003
- MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall SurvivalBreast Cancer Research and Treatment, 2003
- Matrix Metalloproteinase-2 (MMP-2) in T1–2N0 breast carcinomaBreast Cancer Research and Treatment, 2003
- Matrix Metalloproteinase-2 (MMP-2) is Associated with the Risk for a Relapse in Postmenopausal Patients with Node-Positive Breast Carcinoma Treated with Antiestrogen Adjuvant TherapyBreast Cancer Research and Treatment, 2001
- Matrix metalloproteinasesEuropean Journal Of Cancer, 2000
- MMP-2 positivity and age less than 40 years increases the risk for recurrence in premenopausal patients with node-positive breast carcinomaBreast Cancer Research and Treatment, 1999
- Proteolysis in human breast and colorectal cancerBritish Journal of Cancer, 1999
- Regulation of matrix metalloproteinase expression in tumor invasionThe FASEB Journal, 1999
- Expression of gelatinases A and B, stromelysin-3 and matrilysin genes in breast carcinomas: clinico-pathological correlationsClinical & Experimental Metastasis, 1998
- Production of Matrix Metalloproteinases and Tissue Inhibitors of Metalloproteinases in Human Breast CarcinomasJapanese Journal of Cancer Research, 1996